Loading...
Docoh

SOPHiA Genetics (SOPH)

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

SOPH stock data

Analyst ratings and price targets

Last 3 months

Calendar

15 Mar 22
16 Aug 22
31 Dec 22
Quarter (USD) Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
15.3% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 27 18 +50.0%
Opened positions 16 7 +128.6%
Closed positions 7 17 -58.8%
Increased positions 2 4 -50.0%
Reduced positions 5 4 +25.0%
13F shares Current Prev Q Change
Total value 205.12M 191.29M +7.2%
Total shares 23.76M 13.57M +75.2%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Generation Investment Management 6.79M $52.48M 0.0%
Balderton Capital VI, S.L.P. 3.36M $47.4M 0.0%
TROW T. Rowe Price 2.32M $17.93M NEW
Banque Pictet & Cie 2.1M $16.21M NEW
Partner Fund Management 2.01M $15.57M NEW
CS Credit Suisse 1.85M $14.33M NEW
Jennison Associates 1.5M $11.59M +4.0%
PFG Principal Financial Group Inc - Registered Shares 877.19K $6.78M -0.5%
Pura Vida Investments 829.93K $6.42M NEW
Pictet Asset Management 586.3K $4.53M -3.6%
Largest transactions Shares Bought/sold Change
TROW T. Rowe Price 2.32M +2.32M NEW
Banque Pictet & Cie 2.1M +2.1M NEW
Partner Fund Management 2.01M +2.01M NEW
CS Credit Suisse 1.85M +1.85M NEW
Pura Vida Investments 829.93K +829.93K NEW
Driehaus Capital Management 287.41K +287.41K NEW
Pictet & Cie 227.6K +227.6K NEW
RTW Investments 226.59K +226.59K NEW
Fred Alger Management 155.67K +155.67K NEW
Millennium Management 71.78K +71.78K NEW

Financial report summary

?
Competition
Koninklijke PhilipsIlluminaPierianDx

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
Proxies
No filings

Patents

Utility
Methods to compress, encrypt and retrieve genomic alignment data
19 Jul 22
A genomic data decoder may jointly compress and encrypt genomic data alignment information while preserving the privacy of sensitive genomic data elements at retrieval stage.
Utility
Methods for Detecting and Characterizing Microsatellite Instability with High Throughput Sequencing
14 Jul 22
The characterization, classification and reporting of MSI status of patient genomic samples may be provided by high throughput genomic analysis of a set of microsatellite marker loci.
Utility
Methods for Detecting Copy-number Variations In Next-generation Sequencing
28 Apr 22
Copy Number Variants (CNV) detection methods may integrate CNV detection into workflow for next generation sequencer (NGS) data processing, in parallel with SNP and INDEL variant calling.
Utility
Methods for Detecting Copy-number Variations In Next-generation Sequencing
31 Mar 22
Copy Number Variants (CNV) detection methods described herein may efficiently integrate CNV detection into the workflow for a next generation sequencer (NGS) data processing, in parallel with SNP and INDEL variant calling.
Utility
Methods for Identifying Chromosomal Spatial Instability Such As Homologous Repair Deficiency In Low Coverage Next- Generation Sequencing Data
17 Mar 22
A genomic data analyzer may be configured to detect and characterize, with a machine learning model such as a trained convolutional neural network, the presence of a genomic instability in a tumor sample.